Emerging Infectious Diseases in Mongolia by Ebright, John R. et al.
Since 1990, Mongolia’s health system has been in
transition. Impressive gains have been accomplished
through a national immunization program, which was insti-
tuted in 1991. Nevertheless, the country continues to con-
front four major chronic infections: hepatitis B and C, bru-
cellosis, tuberculosis, and sexually transmitted diseases
(STDs). As of 2001, only two cases of HIV infections had
been detected in Mongolia, but concern grows that the rate
will increase along with the rising rates of STDs and
increase in tourism. Other infectious diseases of impor-
tance in Mongolia include echinococcosis, plague,
tularemia, anthrax, foot-and-mouth, and rabies. 
M
ongolia, situated in Central Asia between Russia and
China, has a population of 2.5 million people and an
average population density of 1.5 persons per sq. km.
Twenty-seven percent of the country’s total population
lives in the capital city, Ulaanbaatar. The country is divid-
ed into 21 administrative provinces called aimags with
medical care delivered in each province through a three-
tiered system; referral to any of the university joint hospi-
tals in Ulaanbaatar is possible. As of 1997, Mongolia had
25 physicians and 78 hospital beds per 10,000 population,
one of the highest ratios in Asia (1–3).
Major political and healthcare changes began in 1990,
when Mongolia ceased to be under Soviet control and
stopped receiving developmental aid as one of the Eastern
Bloc satellites (2). Since that time, its economy has been
changing from a centrally planned socialist system to a
free market economy with healthcare delivery reflecting
that transition (1,2,4–6).
Although progress is being made, Mongolia continues
to struggle with poor transportation and communication
and limited material (including laboratory) facilities.
Financial difficulties remain a major challenge as the
country seeks to develop economic self-sufficiency and
deliver modern health care to its people (1).
This report results from two onsite visits by one of the
authors (JRE) in September 1999 and May 2001, which
allowed for extensive discussions with infectious diseases
physicians of the National Research Center for Infectious
Diseases (NRCID) and the National Medical University of
Mongolia. In addition, he was able to attend hospital ward
rounds and conduct patient examinations at NRCID, the
Central Hospital of Oncology, First Clinical Hospital, and
Third Clinical Hospital in Ulaanbaatar and to review the
laboratory facilities in those hospitals.
NRCID serves as the major university hospital and
referral center for tuberculosis (TB) and chronic infectious
diseases in Mongolia. It is situated on 7 acres of land in
south Ulaanbaatar and consists of 23 brick buildings con-
structed in 1985 by the Soviet Union. Each building is
free-standing and requires health providers to walk outside
in order to go from building to building (an important point
considering Ulaanbaatar’s severe and prolonged winters).
As a government facility, NRCID is managed and main-
tained through government funds. Patients are provided
care regardless of their ability to pay, and full-time staff
physicians receive government salaries.
The data in the following sections of this report were
derived from three sources. The first represents the annual
cumulative number of specific infectious diseases, which
have a high public health impact in Mongolia. These data
were collected monthly throughout the country by health-
care personnel in all rural districts and provinces, as well
as in Ulaanbaatar, and reported to the Ministry of Health
and Social Welfare. The annual cumulative data for each
disease were summarized and published for the medical
community and general public by the National Statistical
Office (Table). The second source is derived from the per-
sonal discussions held with leaders in public health and
microbiology as well as infectious disease clinicians and
faculty at NRCID, the National Medical University, and
other hospitals in Ulaanbaatar. The third consists of recent-
ly published reports dealing with infectious diseases and
public health issues in Mongolia during the past 10 years
and identified through Medline search.
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A separate building at NRCID is dedicated to manage-
ment of patients with TB. Divided by separate floors into
pediatric, adult, and surgical units, the TB hospital houses
approximately 230 patients and serves as the primary refer-
ral and treatment center for Mongolia. Diagnosis is made
by clinical symptoms, chest x-ray, Mantoux skin test, and
positive acid-fast smears of clinical specimens. Availability
of culture and susceptibility data appears to be inconsistent
but is expected to improve when the National Tuberculosis
Central Laboratory is moved on site at NRCID.
Staff physicians treat all patients with isoniazid,
rifampin, pyrazinamide, and ethambutol (or streptomycin)
for the first 2 months of a standard 6-month treatment
course and administer treatment by direct observation
(DOT). This treatment is an improvement compared with
the TB program of the mid-1990s, when only 29% of
patients received a four-drug treatment course (7). Current
data from the pediatric unit indicate that 93% of patients
became smear-negative after the initial 2-month DOT pro-
gram compared with 100% 5 years ago. This finding is
similar to results (92% smear-negative) reported from a
pilot study that used the same antimicrobial drugs and
DOT program in eastern Mongolia in 1999 (8). On becom-
ing smear-negative, the patients are discharged to their
homes and complete the remainder of their 6-month pro-
gram with isoniazid and rifampin alone. Both the central
hospital and regional clinics cooperate to oversee the com-
pletion of therapy after discharge and to ensure that contact
tracing is performed. Anti-TB medication is available only
through the central TB hospital and regional clinics and not
from private pharmacies. In general, no second-line anti-
TB drugs, except ciprofloxacin, are available in Mongolia.
National statistics show the lowest incidence of TB in
the past 10 years occurred during 1990 to 1994 (1,664
cases, 1990) with a marked increase by 1995 continuing
through 1999 (3,104 cases, 1996; 3,221 cases, 1999) (9).
The increase probably represents a reporting bias resulting
from a relative lack of evaluation and treatment available
during the first few years after Mongolia was no longer
under Soviet control and until the national TB program
was established in 1994 (7). Data from the National
Tuberculosis Central Laboratory in Ulaanbaatar character-
ize the 3,221 cases that occurred in 1999 as follows: pul-
monary, 2,280 cases (70%) with 1,513 diagnosed by posi-
tive sputum smears and 767 (33% of total pulmonary
cases) diagnosed clinically in spite of negative smears; and
extrapulmonary, 941 cases. Susceptibility data available
from the same source indicate primary resistance to isoni-
azid is >10%; streptomycin resistance is >10%; any resist-
ance is 29%; and multiple-resistant isolates is 1.1% (N.
Naranbat, pers. commun.).
Viral Hepatitis
Hospital directors of NRCID as well as senior infec-
tious diseases faculty of the National Medical University
agree that the most common reportable infection in
Mongolia is viral hepatitis. This fact is still true even
though the incidence has decreased from 14,278 cases in
1990 to 5,249 cases in 1999 (9). Information regarding fre-
quencies of specific types of viral hepatitis is more diffi-
cult to obtain. Serologic testing for hepatitis C has been
readily available only since 1999. One physician working
in the NRCID serology laboratory stated that approximate-
ly 30% of its current assays on inpatients with acute or
chronic hepatitis are positive for hepatitis C.  However,
most (80%) acute hepatitis cases in Mongolia appear to
result from hepatitis A (L. Togooch, pers. commun.). A
recent report by Japanese investigators gives seropreva-
lence rates in 150 outpatients in Ulaanbaatar of 39% (hep-
atitis B) and 48% (hepatitis C). All participants in this
study also had volunteered to participate in an epidemio-
logic study of hyperlipidemia at the Central Clinic
Hospital in Ulaanbaatar (10). The incidence of hepatitis B
is falling as a result of two major interventions begun in
1991. At that time, a national immunization program,
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Table. Annual cumulative number of reportable infectious diseases by year, Mongoliaa 
Y 
Disease  1990  1995  1996  1997  1998  1999 
Tuberculosis  1,664  2,543  3,104  2,723  2,806  3,221 
Viral hepatitis  14,278  7,877  8,198  9,394  8,042  5,249 
Brucellosis  —  850  1,158  1,122  1,308  1,482 
Syphilis  705  718  810  1,291  1,329  1,093 
Gonorrhea  2,234  3,308  3,274  2,934  3,486  2,207 
Salmonellosis  866  360  323  256  239  243 
Shigellosis  1,930  1,589  2,294  2,146  1,261  1,383 
Measles  296  558  123  4  8  10 
Mumps  240  255  436  736  1,287  426 
Meningococcal meningitis  776  2,781  881  533  303  242 
Chickenpox  810  401  386  253  375  297 
a(ref. 9, modified) including vaccination against hepatitis B, was started. In
addition, a program to stop the reuse of phlebotomy nee-
dles and needles for injection was begun. Currently, all
such needles are sterile, individually packaged, and dis-
posable. Evidence attesting to the effectiveness of these
interventions is emerging. Edstam et al. report a drop of
hepatitis B carriage from a historical prevalence of 14% to
6.9% in a random cluster sampling of Mongolian 2-year
old children. These encouraging results were found in both
rural as well as urban settings with one dramatic exception.
For unclear reasons, 40% of persons in the rural aimag
Bayanhongor were positive when tested for hepatitis B
surface antigen (11). 
In spite of the overall encouraging decline in hepatitis
B carriage, the impact of chronic hepatitis remains a major
health problem for the country. Hepatocellular carcinoma
is the most common malignancy in Mongolia (followed by
gastroesophogeal, cervical, and lung cancers), and cirrho-
sis remains common enough to justify a 54-bed ward at
NRCID dedicated to the care of patients with the disease.
Although injection drug use appears to be rare, alcohol
abuse is very common and almost certainly contributes to
Mongolia’s problem with chronic liver disease (12). 
Infectious disease physicians at the National Medical
University and NRCID are well aware of the use of inter-
feron for treatment of chronic hepatitis B and C but have
been limited in utilizing it, primarily because of its
expense. Only approximately 100 patients had been treated
with interferon by 2001.
Brucellosis
Approximately 23% of Mongolia’s population lives in
rural areas and leads a nomadic or seminomadic way of
life. Their diet is heavily dependent on meat and dairy
products, reflecting the importance that large domesticated
animals have played in the country’s history. In the past
decade, the number of livestock has increased from 26 mil-
lion to over 33 million, including 26 million sheep and
goats, 3.8 million cattle, 3.1 million horses, and 350,000
camels (13). Not surprisingly, brucellosis remains one of
the major veterinary and public health problems in
Mongolia. The Brucella seroprevalence rate among cattle
in 1987 ranged from 3.8% to 35% before a vaccination
program (14) but now appears to be approximately 5%-
10% with some focal areas close to 50% (Andrea Mikolon,
pers. commun.). Seroprevalence in sheep and goats is less,
approximately 2%. Nevertheless, Brucella melitensis
appears to be the most common species of Brucella isolat-
ed from blood cultures taken from acutely ill patients
(Andrea Mikolon, pers. commun.). In Mongolia, transmis-
sion to humans occurs primarily from direct contact with
animals through injury while handling them or during
slaughtering and to a lesser extent, from drinking contam-
inated milk (Andrea Mikolon, pers. commun.). As of 2001,
approximately 8,000 human cases of chronic brucellosis
were reported, and 1,000–1,500 new cases have been
reported yearly since 1996 (9) (compared with approxi-
mately 100 cases annually in the United States [15]). Such
a high caseload in this sparsely populated country is
reflected in a 50-bed unit at NRCID dedicated to caring for
people with this disease. Most patients on that unit appear
to have chronic skeletal disease diagnosed by clinical fea-
tures, x-ray findings, and positive serologic results.
Cultures are rarely done because of lack of appropriate
safeguards for this level III pathogen, but they may be per-
formed occasionally at the University Central Laboratory
of the National Medical University. Confirmation and spe-
ciation by using polymerase chain reaction (PCR) may
also be obtained at the same facility. Treatment with doxy-
cycline and gentamicin or rifampin is standard on the unit,
but they are often administered for only 2 weeks rather
than the minimal 6 weeks recommended in most recent
reviews (15,16). Possibly, as a result, many of the inpa-
tients have a history of relapsing disease and have been
admitted for treatment on multiple previous occasions.
Attempts to control this enzootic infection have been
unsuccessful because of an inconsistent strategy varying
between vaccination of livestock and the destruction of
infected animals. As of 2001, no uniform animal vaccina-
tion program existed in Mongolia. However, the World
Health Organization has recently been conducting meet-
ings with the Ministry of Health and the National Medical
University to further assess the health impact of brucellosis
in the country and make recommendations for its control.
Sexually Transmitted Diseases
Sexually transmitted diseases (STDs) have become an
increasing problem since Mongolia became fully inde-
pendent of Soviet control in 1990. This increase may relate
partly to temporary loss of central governmental control as
well as a decreased economic base for the country. (The
Soviet Union had provided 85% of developmental aid to
Mongolia, amounting to 35% of the government’s annual
budget [2]). Physicians at NRCID estimate that 600–1,100
female prostitutes lived in the country in 2001 and suggest,
although data are incomplete, that this number represents
an increase over the previous decade. 
Reported cases of syphilis ranged from 705 to 810
annually during the years 1990 through 1996, but
increased to 1,291 in 1997 and 1,329 in 1998. For most of
the past decade, gonorrhea was reported in over 3,000
patients yearly except in 1990 (2,234 cases) and 1999
(2,207 cases) (9). These official statistics coincide with the
perception of infectious diseases physicians of NRCID
that the STD rate has increased since 1990. In addition, a
1997 report by Purevdawa et al. gives further support for
Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 9, No. 12, December 2003 1511
PERSPECTIVEthis concern. The authors state that rates of  syphilis, gon-
orrhea, and trichomoniasis cases per 100,000 population
increased from the mid-1980s (or 1993 in the case of
syphilis) to 1995 as follows: syphilis, 18 to 32; gonorrhea,
51 to 142; and trichomonas, 47 to 155 (17). A recent study
conducted in Ulaanbaatar among 260 patients attending a
STD clinic found the prevalence of gonorrhea, chlamydia,
and syphilis to be 31.1%, 8.1%, and 8.6%, respectively, for
male patients and 10.3%, 9.9%, and 6.0% for female
patients. Seventy-seven percent of female patients had tri-
chomoniasis and nearly 20% of male patients had non-
gonococcal urethritis (18). Similar results were found in
110 women attending an STD clinic in Ulaanbaatar from
whom genital samples obtained by insertion and immedi-
ate removal of tampons were tested by using PCR amplifi-
cation.  Chlamydia trachomatis (14%),  Neisseria gonor-
rhoeae (11%), and human papillomavirus (HPV) (36%)
were detected in the samples. Forty-four percent of the
women with human papillomavirus had oncogenic geno-
types detected (19).
In addition, antimicrobial drug resistance has become
common in N. gonorrhoeae isolates. Forty-eight percent to
>50% have been found to be resistant to penicillin; close
to 15% are resistant to tetracycline, and nearly 25% are
resistant to ciprofloxacin (20,21). 
Approximately 20,000 patients have been screened for
HIV infection at NRCID every year since 1987. The labo-
ratory uses a microtiter agglutination system obtained
from Japan as a rapid screen and enzyme-linked
immunosorbent assay (ELISA) from either Japan or Italy
as second-level tests on samples found positive by using
the screen. As of 2001, two patients were positive: one
acquired HIV in another country, and the second is thought
to have acquired HIV through contact with an African per-
son visiting Mongolia. Nevertheless, the increased rates of
STDs since the mid-1980s, in addition to increased
tourism in the country, raise concern that HIV will become
a problem in Mongolia and justify the public health educa-
tion initiatives already taking place.
Respiratory Tract Infections, Infectious Causes
of Diarrhea, and Parasitic Infections
Respiratory tract infections and diarrhea are very com-
mon in Mongolia, especially among children. Generally,
respiratory illnesses including pneumonia are most com-
mon during the winter and, at least in 1991, accounted for
most the country’s infant mortality rate (2). Officially, the
infant mortality rate in 1990 was 64.4 per 1,000 live births
and decreased to 37.3 per 1,000 live births in 1999 (22).
Infectious diarrhea, on the other hand, is more problem-
atic during the short summer season. Laboratories in the
major hospitals of Ulaanbaatar including NRCID identify
enteric bacterial pathogens by using manual methods. The
most commonly identified pathogens have been Shigella
flexneri and  Salmonella  species such as S. enteritidis
Typhimurium (D. Regzedmaa, pers. commun.). However,
supplies and equipment necessary to isolate and identify
Campylobacter species, enterotoxigenic and enterohemor-
rhagic Escherichia coli, and rotavirus are not available;
consequently, information regarding the prevalence of
these organisms is not available.
An outbreak of cholera involving approximately 100
persons occurred in 1996 but was rapidly brought under
control. No cases have been identified since that time, and
the source of the outbreak remains uncertain. Typhoid
fever appears to be uncommon. At NRCID, one case has
been recognized since 1999. In that instance, a 42-year-old
man with fever, diarrhea, and a perforated small bowel
required resection after he had treated himself before hos-
pitalization with ampicillin and gentamicin.
Official statistics show a gradual decline in reported
cases of salmonellosis and dysentery from 866 and 1,930
cases, respectively, in 1990, to 243, and 1,383 cases in
1999 (9). Nevertheless, infectious diarrhea remains a
major health problem during the summer months in
Ulaanbaatar and a 34-bed unit at NRCID is dedicated to
the care of patients with this disease.
The director of the enteric parasite laboratory at
NRCID reported that Enterobius vermicularis constituted
approximately 90% of detected intestinal parasites. The
remainder consisted of Ascaris lumbricoides and Taenia
species. This finding corresponds with a recent survey of
rural residents near Ulaanbaatar which found that enterobi-
asis and hydatidosis were the two major helminthic infec-
tions in Mongolia. Lee et al. offered the speculation that
soil-transmitted parasites such as A. lumbricoides are less
common because soil-derived vegetables are not common-
ly included in the typical Mongolian diet (23).
Most households in rural Mongolia own livestock
(sheep, goats, horses, cattle) and over 50% own dogs. Not
surprisingly, human infection with Echinococcus granulo-
sis is seen by physicians in Ulaanbaatar, although less fre-
quently than in the neighboring northern provinces of
China. A recent survey conducted in northwest Mongolia
detected a seroprevalence of 5% by using an ELISA on
334 persons (24). An earlier report by Davaatseren et al.
claimed echinococcus was the cause for 18% of the surgi-
cal cases in the First Clinical Hospital of Ulaanbaatar in
1993 (25).
Other Infectious Diseases
Cases of plague, due to infection with Yersinia pestis,
have been seen in approximately 40 patients each year,
especially in rural Mongolia. Transmission appears usual-
ly to occur as a result of hunting marmots (Marmota sibir-
ica), large rodents especially plentiful throughout the vast
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occurred in Mongolia’s western-most province (aimag),
Bayan Olgii; the 93 persons who had contact with the
patient received prophylactic tetracycline. Enzootic plague
also may be maintained in the Mongolian gerbil (Meriones
unguiculatus) and its flea (Nosopsyllus laeviceps) (26).
Occasional cases of tularemia have been reported in
Mongolia. Animal cases of anthrax involving cattle, sheep,
and goats are reported sporadically in the country.
Occasional human cases of cutaneous or intestinal anthrax
also have been reported. An animal vaccine is available but
has not been administered as part of a nationwide program.
Bovine spongioform encephalopathy is unknown in
Mongolia and is not anticipated because all cattle are
strictly pasture-fed. On the other hand, foot-and-mouth
disease caused by apthovirus of the family Picornaviridae,
although thought to be eradicated in 1973, reappeared
along the Chinese border in the year 2000. More recently,
it spread from the eastern Mongolian provinces and by
March 2001 appeared among the livestock on the outskirts
of Ulaanbaatar. Prompt intervention including livestock
vaccination brought the outbreak under control, and most
districts around the capital city had their quarantine lifted
by May 2001.
Rabies remains an endemic problem especially among
dogs and wolves, with occasional human cases reported.
Although rabies immunoglobulin and human diploid cell
vaccine are not available, a locally produced, goat
brain–derived vaccine is available for use in Mongolia.
Lyme disease is not reported in the country, but a recent
study in northeastern China (Inner Mongolia) documented
Borrelia garinii and B. afzelii in Ixodes persulcatus ticks
(27). Therefore, the possibility exists of human disease
occurring in Mongolia. Tick-borne encephalitis due to a
flavivirus infection and hemorrhagic fever with renal syn-
drome, both present in Russia, are not recognized in
Mongolia (28). 
Antimicrobial Drug Resistance
Antimicrobial drugs generally available at NRCID
include penicillin G, ampicillin, oxacillin, cephalosporins,
including ceftriaxone and cefotaxime, gentamicin, chlo-
ramphenicol, ciprofloxacin, tetracycline, erythromycin,
trimethoprim-sulfamethoxazole, rifampin, isoniazid,
ethambutol, and pyrazinamide. Aminoglycoside blood lev-
els were not routinely available, as of 2001, although they
could be obtained through private specialty laboratories in
Ulaanbaatar.
Oral antimicrobial drugs have been preferred over
those administered parentally, whenever possible. Sterile
intravenous infusion solutions are available and prepared
locally at each major hospital in Ulaanbaatar. However,
intravenous catheters are not readily available, which
necessitates that intravenous antimicrobial drugs be given
through sterile needles. These needles are promptly
removed after each infusion. As of 2001, antimicrobial
drugs are commonly prescribed for at least 3 postoperative
days to patients undergoing even minor surgery (such as
simple lipoma removal) to reduce the incidence of postop-
erative wound infections.
Each major hospital in Ulaanbaatar has its own bacteri-
ology laboratory, where organisms are identified by using
manual methods and susceptibilities are determined by
using antimicrobial drug disks. Nevertheless, antimicro-
bial drug susceptibility profiles appear to be unavailable.
Several hospital laboratories could not, for example, pro-
vide information regarding their prevalence of methicillin-
resistant Staphylococcus aureus (MRSA). The director of
the The World Health Organization (WHO)-sponsored
PCR section of NRCID central laboratory reported a rate
of 20% to 30% MRSA. However, no details or written
reports were available for review.
Hospital Infection Control
Sinks and bar soap are available throughout all hospi-
tals. Individual paper towels were not present, however,
and reusable cloth towels were used in their place.
Healthcare providers, as a rule, did not wash their hands
between examining patients during rounds; rather, hand
washing generally was done only at the end of rounds after
all patients had been seen.
Immunization
Mongolia’s current national immunization program
began in 1991 and includes vaccines against TB, polio,
hepatitis B, diphtheria, pertussis, tetanus, and measles. As
of 2001, the vaccination rate for all children in the country
was 98%. Immunization against rubella was to be added to
the official program during 2002. Mumps vaccine is not on
the official vaccination schedule, however. Of interest, an
outbreak of mumps occurred in Ulaanbaatar during the
spring of 2001. Mongolia did not experience the outbreak
of diphtheria in the 1990s as Russia did (28). Four cases
were reported for the country in 2000. WHO certified that
Mongolia was free of polio in 2000. Immunization against
influenza is sporatic and dependent on outside funding. (L.
Togooch, pers. commun.). 
Summary
Since 1990, Mongolia’s health system has been in tran-
sition. Impressive gains have been accomplished through
their national immunization program, started in 1991. Of
particular note is the decreased incidence of acute hepati-
tis B. Nevertheless, the country continues to struggle with
chronic hepatitis B- and C-related liver failure and hepato-
cellular carcinoma (exacerbated by alcoholism, an addi-
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other major infectious disease problems include brucel-
losis, TB with significant single drug resistance being
identified, and rising rates of STDs. Respiratory illnesses
including pneumonia constitute a major cause of infant
deaths, especially during the prolonged winters, and infec-
tious diarrhea remains a common public health problem
during the summers. 
As of 2001, only two HIV infections have been detect-
ed in Mongolia. Nevertheless, public health leaders remain
concerned that its incidence may soon increase. Other
infectious diseases of importance include echinococcus,
plague, tularemia, anthrax, foot-and-mouth, and rabies.
Antimicrobial drugs are available to the public without
prescription and also may be given excessively to postop-
erative patients. Antimicrobial drug–susceptibility trends
generally are not available at the major teaching hospitals
in Ulaanbaatar. Infection control policies, especially hand-
washing, appear to need more attention.
Challenges
We conclude with our recommendations emphasizing
areas for focus and further development, which would
seem most applicable and potentially beneficial over the
next 10 years. Further progress in transitioning from the
clinical diagnosis of TB to diagnosis confirmed by wide-
spread availability of culture for Mycobacterium tubercu-
losis (with accompanying antimicrobial drug–susceptibili-
ty results) will be a great help in directing limited
resources and optimizing individual treatment programs
by using DOT. Given the high prevalence of chronic viral
hepatitis (and for other reasons related to social and eco-
nomic development issues), a national program that
reduces individual excessive alcohol consumption through
education and treatment centers is appropriate. A national,
consistently applied program to reduce the prevalence of
Brucella infection of animal livestock is needed.
Continued emphasis on public health measures to reduce
the spread of sexually transmitted diseases and prevent the
incursion of HIV is of great importance. A national pro-
gram for control of antimicrobial drug use based upon
physician prescription rather than general public access is
necessary. A system of consistently performing suscepti-
bility studies on common bacterial isolates with subse-
quent publication of antimicrobial drug–susceptibility
trends, at least in the referral hospitals in Ulaanbaatar,
would be an important advance. Hospital infection control,
including handwashing between individual patient exami-
nations and antimicrobial drug use policies, needs to be
further developed in Mongolia. Expansion of the excellent
national immunization program to include rubella, mumps,
influenza, and possibly haemophilus vaccines would pro-
vide additional benefit to the people of Mongolia.
Dr. Ebright is an associate professor in the Department of
Internal Medicine, Division of Infectious Diseases, and director
of Medical Education at Wayne State University. His research
interests are in clinical infectious diseases and include travel
medicine, infectious diarrhea, and endocarditis.
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